Anti-PD-L1 (Atezolizumab), Humanized Antibody

Monoclonal human IgG1 antibody against human PD-L1
Catalog #: A1305

Availability: In stock


Product Details

Cat # +Size A1305-100
Size 100 µg
Antibody Target PD-L1
Alternate Name Tecentriq, PD-L1
Host Human
Antibody Type Monoclonal
Isotype Human IgG1
Immunogen Human programmed cell death 1 ligand 1 (PD-L1)
Accession # Q9NZQ7
Gene ID 29126
Appearance Colorless liquid
Formulation In phosphate buffered saline, pH 7.4
Purification Affinity purified
Species Reactivity Human
Application Neutralization, ELISA
Application & Usage Neutralization: 0.1-1 μg/ml, ELISA: 1 μg/ml
Handling The antibody solution should be gently mixed before use
Storage Conditions -20°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.


Atezolizumab (Tecentriq) is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1). Atezolizumab blocks the interaction of PD-L1 with PD-1 and induces anti-tumor immune reactivation.
Subscribe to our Newsletter!!
and automatically get enrolled into a raffle to win Google Home.
Offer valid for US customers only.
Instant 5% OFF
from your order?
Your coupon is below!
Coupon: df56s5d8